Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions

Clinical and Experimental Allergy

Volumn 30, Issue 6, 2000, Pages 847-855

  Yawalkar, N ^a,b   Egli, F ^a   Hari, Y ^a   Nievergelt, H ^a   Braathen, L R ^a   Pichler, W J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Drug allergy; Granzyme B; IFN ; IL 12; Immunohistochemistry; Perforin

Indexed keywords

CD1 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANZYME B; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR; PERFORIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DERMOEPIDERMAL JUNCTION; DRUG ERUPTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; DRUG ERUPTIONS; EXANTHEMA; FEMALE; GRANZYMES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-12; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034038730     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00847.x     Document Type: Article

References (30)

1. 1 Breathnach SM. Mechanisms of drug eruptions. Part I Australas J Dermatol 1995; 36:121-7.
2. 2 Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 1998; 19:133-41.
3. 3 Hertl M, Merk HF. Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 1995; 105:95S-98S.
4. 4 Pichler WJ, Schnyder B, Zanni MP, Hari Y, von Greyerz S. Role of T cells in drug allergies. Allergy 1998; 53:225-32.
5. 5 Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ. Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 1995; 55:2670-8.
6. 6 Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E, von Greyerz S, Bircher A, Pichler WJ. Characterization of lidocaine-specific T cells. J Immunol 1997; 158:1139-48.
7. 7 Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct. MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 1997; 100:136-41.
8. 8 Schnyder B, Frutig K, Yawalkar N, Limat A, Pichler WJ. T cell cytotoxicity in sulphamethoxazole induced skin reaction. Clin Exp Allergy 1998; 28:1412-7.
9. 9 Fitzpatrick L, Makrigiannis AP, Kaiser M, Hoskin DW. Anti-CD3-activated killer T cells, interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity. J Interferon Cytokine Res 1996; 16:537-46.
10. 10 Ma X, Aste-Amezaga M, Gri G, Gerosa F, Trinchieri G. Immunomodulatory functions and molecular regulation of IL-12. In: Adorini L. eds. IL-12 Chem Immunol, Vol 68, Basel: Karger, 1997: 1-22.
11. 11 Salcedo TW, Azzoni L, Wolf SF, Perussia B. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol 1993; 151:2511-20.
12. 12 Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27:175-81.
13. 13 Yawalkar N, Reimers A, Hari Y, Hunziker TH, Gerber H, Müller U. Pichler WJ. Drug-induced linear IgA bullous dermatosis associated with ceftriaxone-and metronidazole-specitic T cells. Dermatology 1999; 199:25-30.
14. 14 Yawalkar N, Egli F, Brand CU, Pichler WJ, Braathen LR. Antigen-presenting cells and keratinocytes express Interleukin 12 in allergic contact dermatitis. Contact Dermatitis 2000; 42:18-22.
15. 15 Ulfgren AK, Lindblad S, Klareskog L, Andresson J, Andresson U. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheumatic Diseases 1995; 54:654-61.
16. 16 Hameed A, Olsen KJ, Cheng L, Fox WM, Hruban RH, Podack ER. Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. Am J Pathol 1992; 140:1025-30.
17. 17 Kummer JA, Kamp AM, van Katwijk M, Brakenhoff JP, Radosevic K, van Leeuwen AM, Borst J, Verweij CL, Hack CE. Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins. J Immunol Methods 1993; 163:77-83.
18. 18 Kauppinnen K, Stubb S. Drug eruptions, causative agents and clinical types. A series of in-patients during a 10-year period. Acta Derm Venereol 1984; 64:320-4.
19. 19 Swanbeck G, Dahlberg E. Cutaneous drug reactions. An attempt to quantitative estimation. Arch Dermatol Res 1992; 284:215-8.
20. 20 Ackerman AB, Chongchitnant N, Sanchez J, Ying G, Bennin B, Reichel M, Randall MB. Inflammatory diseases. In: Stamathis G. eds. Histologic Diagnosis of Inflammatory Skin Diseases 2nd Edn. Baltimore: Williams & Wilkins, 1997:317-28.
21. 21 Chaffins ML, Cockerell CJ. Histopathologic charateristics of common inflammatory skin disorders. In: Current Problems in Dermatology St Louis: Mosby-Year Book 1996:189-236.
22. 22 Griffiths GM. The cell biology of CTL killing. Curr Opin Immunol 1995; 7:343-8.
23. 23 Liu CC, Walsh CM, Young JD. Perforin: structure and function. Immunol Today 1995; 16:194-201.
24. 24 Masson D, Tschopp JA. family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 1987; 49:679-85.
25. 25 Squier MK, Cohen JJ. Cell-mediated cytotoxic mechanisms. Curr Opin Immunol 1994; 6:447-52.
26. 26 Trapani JA. Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the poreforming protein, perforin, and the serine protease, granzyme B. Aust N Z J Med 1995; 25:793-9.
27. 27 Liu CC, Rafii S, Granelli-Piperno A, Trapani JA, Young JD. Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med 1989; 170:2105-18.
28. 28 Susskind B, Shornick MD, Iannotti MR, Duffy B, Mehrotra PT, Siegel JP, Mohanakumar T. Cytolytic effector mechanisms of human CD4+ cytotoxic T lymphocytes. Hum Immunol 1996; 45:64-75.
29. 29 Vergelli M, Hemmer B, Muraro PA, Tranquill L, Biddison WE, Sarin A, McFarland HF, Martin R. Human autoreactive CD4+ T cell clones use perforin-or Fas/Fas ligand-mediated pathways for target cell lysis. J Immunol 1997; 158:2756-61.
30. 30 Zanni MP, von Greyerz S, Schnyder B, Brander KA, Frutig K, Hari Y, Valitutti S, Pichler WJ. HLA-restricted, processing-and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. J Clin Invest 1998; 102:1591-8.